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nificantly upregulated following LTA-SA and β-1,3-glucan 
exposure (toll-like receptor-2 ligands), but not following LPS 
stimulation.  Conclusions: Basophils from allergic and healthy 
subjects constitutively express membrane BAFF, which is not 
upregulated by IgE or specific allergens but by TLR-2 ligands 
(LTA-SA and β-1,3-glucan ). Aspergillus fumigatus stimulation 
was able to upregulate BAFF expression on the basophils of 
sensitized asthmatic patients, but not via IgE-dependent 
mechanisms, since results did not differ between the patient 
and control groups. These findings suggest that basophils 
may contribute to the polyclonal production of IgE common-
ly observed in patients with SAFS and ABPA. 
 © 2015 S. Karger AG, Basel 
 Introduction 
 B-cell-activating factor (BAFF) is an important regula-
tor of B-cell activation, proliferation and immunoglobu-
lin production. It plays an important role in autoimmune 
diseases  [1] . Recent observations indicate that BAFF may 
also play a role in respiratory allergic diseases  [2] . Allergic 
rhinitis and asthma are characterized by the production 
of IgE specific for ubiquitous allergens (e.g. pollen, mites 
and molds); in some patients, an increase in total unspe-
cific IgE may be observed, particularly in patients with 
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 Abstract 
 Background: To investigate the modulation of B-cell-activat-
ing factor (BAFF) expression on the basophil membrane of 
allergic patients. BAFF is an important regulator of B-cell ac-
tivation, proliferation and immunoglobulin production, 
which may play a role in respiratory allergic diseases in pro-
moting the production of IgE by B cells.  Methods: Peripheral 
blood samples of 10 patients with allergic rhinitis, 3 with se-
vere asthma and fungal  sensitization (SAFS), 3 with allergic 
bronchopulmonary aspergillosis (ABPA) and 11 healthy con-
trols were assessed regarding BAFF (CD257) expression us-
ing the basophil activation test before and after stimulation 
with IgE and allergens, as well IgE-independent stimuli, like 
fMLP, lipotheichoic acid from  Staphylococcus aureus (LTA-SA) 
and lipopolysaccharide (LPS).  Results: BAFF membrane ex-
pression did not change after IgE and allergen stimulation 
both in patients and controls, while it was upregulated by 
 Aspergillus stimulation, both in sensitized patients and con-
trols. In both patients and controls, BAFF expression was sig-
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severe asthma combined with fungal sensitization (SAFS) 
 [3] or with allergic bronchopulmonary aspergillosis 
(ABPA)  [4] . B-cell-stimulating factors such as BAFF are 
thought to play a role in promoting the production of IgE 
by B cells. It has been shown that allergen-specific B cells 
are activated and undergo class switch recombination at 
allergic reaction sites  [5, 6] , and the release of BAFF in 
bronchoalveolar lavage fluid has been reported after spe-
cific allergen challenge in allergic asthmatics  [2] . Baso-
phils are an important component of both immediate al-
lergic reactions and chronic inflammation, and due to 
their myeloid origin, these cells may be a source of BAFF 
production. The mechanisms of BAFF expression or re-
lease by basophils are only partly known. Chen et al.  [7] 
demonstrated that IgD-binding antigens increased baso-
phil expression of BAFF, and activation of toll-like recep-
tors (TLRs) in basophils from healthy controls induced 
IgG4 production by B cells, an effect associated with en-
hanced production of BAFF  [8] . These observations also 
point to a role of basophils in adaptive immune respons-
es, similar to other cells of the innate immune system, 
including neutrophils, macrophages and monocytes  [9, 
10] . The aim of this study was to investigate whether 
BAFF is expressed on the basophil membrane of allergic 
patients and whether its membrane expression is in-
creased by IgE-dependent stimuli, such as allergen expo-
sure, and/or IgE-independent stimuli, including TLR en-
gagement. Specifically, we were interested to investigate 
the effect of  Aspergillus stimulation on BAFF expression 
on the basophil membrane of patients with SAFS or 
ABPA, who showed high serum levels of total IgE.
 Patients and Methods 
 Study Design 
 Peripheral blood samples of 16 allergic rhinitis patients (aged 
48 ± 17.1 years: 10 males and 6 females) with or without asthma 
and 11 healthy controls (aged 51 ± 12.5 years; 7 males and 4 fe-
males) were assessed for BAFF (CD257) expression following the 
basophil activation test (BAT) before and after IgE stimulation 
with specific allergens (e.g. grass, ragweed and  Aspergillus fumiga-
tus ) and the TLR-4 ligand, lipopolysaccharide (LPS). In the 6 
 Aspergillus -sensitized patients (3 had severe asthma, total IgE: 
418 ± 348 kU/l; 3 had ABPA, total IgE: 2,399 ± 1,265 kU/l), BAT 
was also performed after stimulation with the TLR-2 ligands, li-
potheichoic acid from  Staphylococcus aureus (LTA-SA) and β-1,3-
glucan from  Euglena gracilis , as well as fMLP, as IgE-independent 
stimuli. BAFF mRNA expression was quantified by RT-PCR in 2 
patients and 2 controls. All the patients and controls gave their in-
formed consent to participate in the study, which was approved by 
the local institutional review board. The patients’ demographic 
and clinical characteristics are reported in  table 1 .
 Basophil Activation Test  
 BAT was performed according to a previously reported tech-
nique. Briefly, endotoxin-free heparinized whole-blood samples 
were obtained from allergic patients and healthy controls. Cells 
were challenged with 100 μl of anti-IgE (10 μg/ml; clone G7-18; 
BD Bioscience, USA), allergens (0.2 μg/ml ragweed, 2.5 μg/ml 
grass and 2.5 μg/ml  A. fumigatus; ALK Abelló, Italy), fMLP 
(0.5 μg/ml; Sigma Aldrich, Italy) or TLR ligands (1 μg/ml LTA-
SA and 2.5 μg/ml β-1,3-glucan; both from InvivoGen, USA, and 
1 μg/ml LPS from  Escherichia coli ; Sigma Aldrich) for 20 min at 
37  °  C in a water bath (optimal stimulation times were assessed in 
previous experiments). The optimal stimulation concentrations 
of the anti-IgE, allergens, fMLP and TLR ligands were established 
in preliminary experiments. As a negative control, Tyrode solu-
tion (Sigma Aldrich) with 20 μ M HEPES and 7.5% NaHCO 3 , pH 
7.4, was used to assess the spontaneous expression of the different 
markers. The reactions were terminated by chilling the cells on 
ice.
 Immunophenotyping and Flow-Cytometric Analyses 
 Basophils were stained with 5 μl of anti-human FcεRIα-Pacific 
Blue (BioLegend, USA), 10 μl of anti-human CD63-FITC (clone 
H5C6; BD Biosciences), 10 μl of anti-human CD203c-APC (clone 
NP4D6; BioLegend) and 10 μl of monoclonal anti-human CD257-
PE (BioLegend) for 20 min on ice. Flow-cytometric analyses were 
performed on a FACSCanto II flow cytometer (BD Immunocy-
tometry Systems, USA). Side scatter and anti-IgE+/CD203c+ 
staining were applied to gate out at least 500 basophils. BAFF pos-
itivity was set on basophils with a fluorescence intensity that was 
above the level of the 99th percentile of a FMO (Fluorescence Mi-
nus One) sample. 
 Basophil Purification 
 Basophils were isolated using immunomagnetic methods 
(MACS basophil isolation kit II; Miltenyi). Briefly, PBMCs from 
2 healthy subjects and 2 allergic patients were resuspended in PBS 
with 0.5% BSA and 2 m M EDTA, and were incubated with a baso-
phil biotin antibody cocktail after FcR blocking. The basophils that 
were assessed by flow cytometry (using FcεRIα-Pacific Blue and 
CD203c-APC) accounted for more than 95% of the total cells.
 Table 1.  Clinical and demographic characteristics of the allergic 
patients (n = 16) grouped according to allergen sensitization
Ragweed Grass A. fumigatus Total IgE, 
kU/l 
(mean ± SD)
Gender
Male 2 4 4 –
Female 3 1 2 –
Age 
(mean ± SD) 39.5±13.5 57±12.5 60±15.5 –
Rhinitis 3 2 – –
Rhinitis + asthma 2 3 – –
Severe asthma – – 3 418±347.8
ABPA – – 3 2,399±1,265
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 Real-Time PCR Analysis for BAFF mRNA Expression  
 Total RNA from purified basophils was extracted after lysis in 
TRIzol reagent (Invitrogen Life Technologies). RNA samples 
were reverse transcribed at 42  °  C with a reverse transcription sys-
tem (Promega, USA) according to the manufacturer’s instruc-
tions, and the subsequent cDNA was used for real-time PCR. 
Quantitative real-time PCR assays were performed using primers 
that specifically amplified BAFF and G6PD (Hs00198106_m1 and 
Hs00166169_m1, respectively; purchased from Applied Biosys-
tems). RT-PCR was performed with a BioRad iQ iCycler (BioRad, 
USA) and analyzed with the gene expression analysis for iCycler 
iQ real-time PCR detection system software (BioRad). BAFF and 
G6PD primer amplification efficiencies were validated in a pre-
liminary experiment. For PCR analysis, each sample was run in 
duplicate in separate tubes. The results were normalized to a 
housekeeping gene (G6PD), as shown by Vandesompele et al. 
 [11] .
 Statistics 
 All the variables are reported as means ± SD. Comparisons be-
tween patients and controls were performed using Student’s t test 
for paired data. All statistical analyses were performed using 
GraphPad, Prism 4.
 Results 
 BAFF was constitutively expressed on the basophil 
membrane ( fig. 1 ), with no difference between the allergic 
patients (19 ± 15.8% basophils) and controls (19.3 ± 
10.5% basophils).
 BAFF mRNA Expression  
 BAFF mRNA expression on purified nonstimulated 
basophils did not differ between patients and controls, 
confirming the flow-cytometric finding (data not shown). 
 IgE-Dependent Stimuli 
 BAFF membrane expression did not change after IgE 
stimulation in both patients and controls (from 19 ± 15.8 
to 25.3 ± 17.4 in patients, and from 19.3 ± 10.5 to 19.6 ± 9.6 
in controls), whereas CD63 was upregulated as expected. 
BAFF membrane expression did not significantly change 
following grass and ragweed stimulation (from 13.8 ± 17.8 
to 23.5 ± 16.8 in patients, and from 17.7 ± 9.6 to 23.6 ± 9.4 
in controls), whereas CD63 expression was significantly 
upregulated (from 0.33 ± 0.12 to 33.4 ± 0.28, p < 0.0001) 
on the allergic patients’ basophil membranes as expected.
 Aspergillus Stimulation 
 BAFF expression was significantly upregulated on the 
basophil membrane of patients and controls following  A. 
fumigatus stimulation (from 27.7 ± 11.7 to 57 ± 17.1 in 
patients, p = 0.0012, and from 27.8 ± 6.2 to 58.3 ± 7.6, p = 
0.0002, in controls;  fig. 2 a).
 IgE-Independent Stimuli 
 In both patients and controls, BAFF expression was 
significantly upregulated following LTA-SA (from 26.4 ± 
12.9 to 63 ± 10.6 in patients, p = 0.0063, and from 20 ± 8.7 
 Fig. 1. The effect of basophil stimulation on membrane BAFF expression in a patient. Basophils were gated as IgE+/CD203c+.  A. fu-
migatus , LTA-SA and β-1,3-glucan induce significant upregulation of BAFF on the basophil membrane. 
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to 55.2 ± 16.8 in controls, p = 0.023) and β-1,3-glucan ex-
posure (from 26.4 ± 12.9 to 53.4 ± 18 in patients, p  = 
0.036, and from 20 ± 8.7 to 55.5 ± 19.7 in controls, p = 
0.021). Following fMLP exposure, BAFF expression did 
not significantly increase in patients (from 26.4 ± 12.9 to 
45.6 ± 16.5, p = 0.15); however, it increased almost sig-
nificantly in controls (from 20 ± 8.7 to 45.7 ± 19, p = 0.06). 
Additionally, LPS stimulation did not change BAFF ex-
pression in either patients or controls ( fig. 2 b).
 Discussion 
 Our results show that basophils of allergic and healthy 
subjects constitutively expressed membrane BAFF and 
that its expression was not upregulated by IgE or specific 
allergens, though it was upregulated by TLR-2 ligands 
(LTA-SA and β-1,3-glucan).  A. fumigatus stimulation 
was able to upregulate BAFF expression on the sensitized 
asthmatic patients’ basophils, which showed also in-
creased CD203c and CD63 expression, as expected. The 
mechanism of BAFF expression could not be explained 
by an IgE-dependent pathway, as the same level of BAFF 
upregulation was also observed in nonallergic controls, 
who did not show any changes in CD203c and CD63 ex-
pression. Considering the fast stimulation time (20 min), 
it is conceivable that BAFF is contained in a vesicle stor-
age compartment and that TLR-2 stimulation promotes 
the specific granules to be fused to the plasma membrane 
and expressed. Similarly to the independent CD203c and 
CD63 membrane expression, which is regulated by the 
activation/degranulation of cells  [12] , our results suggest 
that BAFF expression might follow a specific pathway of 
activation that is independent of degranulation/CD63 ex-
pression and CD203c/CD11b expression.
 TLRs recognize fungal pathogen motifs, including  As-
pergillus  motifs, and both TLR-2 and TLR-4 have been 
shown to recognize  A. fumigatus hyphae  [13] . In our ex-
periments, LPS, a TLR-4 ligand, was not able to upregu-
late membrane BAFF, indicating that membrane BAFF 
expression may be upregulated by  A. fumigatus following 
TLR-2 engagement. Watanabe et al.  [8] demonstrated 
that LPS induced the release of BAFF, suggesting a pos-
sible difference between surface expression and the re-
lease of BAFF after TLR-4 stimulation.
 Following fMLP exposure, another IgE-independent 
stimulus, BAFF expression increased, even if the increase 
was not significant, due to the broad distribution of the 
response, suggesting that there is heterogeneity in the 
studied population, where certain individuals have a pro-
pensity to express more BAFF following stimulation with 
fMLP. The reasons for this heterogeneous response are 
not clear.
 We did not measure BAFF release from basophils be-
cause our observation was limited to its membrane ex-
pression, but BAFF membrane expression may be an im-
portant step toward its release. Membrane BAFF cleavage 
by inflammatory cytokines has been reported to be a 
mechanism of BAFF release by neutrophils  [14] . 
 Basophils are cells of myeloid origin, similar to neutro-
phils, and migrate from the blood compartment to in-
flamed tissue, where they act as both effector inflamma-
 Fig. 2. The percentage of BAFF-positive cells at baseline, after IgE and allergen stimulation ( a ), and after non-IgE-related ( b ) stimuli in 
controls and allergic subjects. Rag = Ragweed; grass = grass pollen; Asp =  A. fumigatus . Bas = baseline; β-Gluc = β-1,3-glucan.  *  p < 0.05, 
 * *  p < 0.01. 
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tory cells and cells that are involved in pathways linking 
innate to adaptive immunity. Specifically, basophils may 
help to regulate the adaptive immune response because 
they are a known early source of IL-4 and other cytokines 
associated with Th2 responses  [15] . Our finding that 
BAFF is constitutively expressed on the basophil mem-
brane of allergic patients may have implications for the 
activation of immunoglobulin production and class 
switching recombination. Other cells, such as epithelial 
cells, may produce BAFF and participate in the promo-
tion of local IgE production, as reported for chronic rhi-
nosinusitis with nasal polyps  [16] , where sinonasal tissue 
BAFF mRNA expression was significantly correlated 
with CD20 expression  [17] .
 The upregulation of BAFF expression on the basophil 
membrane that we observed following  Aspergillus stimu-
lation may be related to the huge amount of polyclonal IgE 
production that is commonly observed in patients with 
SAFS and to an even higher degree in ABPA patients, the 
airways of whom are colonized by  Aspergillus  [3, 4] .
 In conclusion, our results demonstrate that basophils 
constitutively express BAFF on their membranes, both in 
allergic and in healthy subjects, and are able to upregulate 
its expression through non-IgE-mediated stimulation. 
These findings suggest that basophils, like other cells of 
innate immunity, help to establish a link between innate 
and adaptive immune responses, specifically following 
TLR stimulation.
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